Market Research Future.com add new report of “Clinical Perinatal Software Market
Research Report – Global Forecast To 2023” it contains Company information,
geographical data and Table of Content
Clinical Perinatal Software Market information: by products (integrated software and
standalone software), by services (implementation services and others), by deployment
models (on-premises and cloud-based), by applications (Fetal monitor data services and
others), and end user - Forecast till 2023
the clinical perinatal software monitor health of fetus and pregnant women. It provides
information about any complexity that may arise during the prenatal period, which helps
to minimize the problems during the pregnancy.
The Global Clinical Perinatal Software Market is growing at a steady pace and is expected
to grow at a CAGR of ~7.2 % during review period 2017-2023. Increasing awareness
and a rising birth rate & post-date pregnancy drive the growth of the market. Moreover,
increasing healthcare expenditure, continuous development in technology, and
increasing government support for research & development likely to boost the demand
for the software. On the other hand, complex user interface and high cost of the
software may slow the market growth over the assessment period.
Some of the key players in this market: General Electric, Edan Instruments, Inc.,
Huntleigh Healthcare Limited, KONINKLIJKE PHILIPS N.V, K2 Medical Systems, PeriGen,
Inc, Cerner Corporation, Trium Analysis Online, and others.
Request a Sample Report @
https://www.marketresearchfuture.com/sample_request/4185.
Clinical Perinatal Software Market has been segmented on the basis of products, which
comprises of integrated software and standalone software.
On the basic of services, the market is segmented into implementation services, support
& maintenance services, training service, customization services, and online resources.
On the basic of deployed models, the market is segmented on-premises and cloud-
based.
On the basis of applications, the market is segmented into fetal monitor data services,
workflow management, and patient documentation.
On the basis of end users, it is segmented into hospital & clinics and maternity clinics.
Regional Analysis of the Global Clinical Perinatal Software Market
The Americas region accounted for a lion share of USD 65.31 million in 2016, owing to
the well-developed technology, high healthcare expenditure, and the presence of the
leading players.
Europe is the second largest market that holds a noticeable share of the Global Clinical
Perinatal Software Market. The European market is expected to grow significantly during
the forecast period owing to well-developed healthcare infrastructure and increasing
investment in healthcare. Germany, the UK, and France contribute significantly to the
growth of the European market.
In Asia Pacific, rising number of hospitals, increasing need for better diagnostic methods,
and demand for cost-effective treatment & diagnostics services are the key factors for
the market growth.
The Middle East & Africa is expected to show steady growth in this market due to low
technology penetration and less availability of innovative healthcare technologies.
Key Findings
The Global Clinical Perinatal Software Market and is expected to reach USD 60 million by
2023.
Integrated software segment on the basis of products holds the largest share of 75.8%
of the market.